Skip to main content
NOVOGENE CO., LTD. logo

NOVOGENE CO., LTD. — Investor Relations & Filings

Ticker · 688315 ISIN · CNE1000052X3 Shanghai Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 558 across all filing types
Latest filing 2023-10-24 Interim / Quarterly Rep…
Country CN China
Listing Shanghai Stock Exchange 688315

About NOVOGENE CO., LTD.

https://www.novogene.com

Novogene Co., Ltd. is a global provider of genomic services and solutions, specializing in next-generation sequencing (NGS) and bioinformatics analysis. The company offers a comprehensive suite of services, including whole genome sequencing, transcriptomics, epigenomics, and metagenomics, alongside specialized solutions for single-cell analysis and clinical diagnostics. Utilizing advanced high-throughput sequencing platforms and proprietary bioinformatics pipelines, Novogene supports research across diverse fields such as human health, agriculture, and environmental science. The organization serves a broad client base encompassing academic institutions, pharmaceutical companies, and biotechnology firms. With a focus on data quality and technical expertise, Novogene facilitates large-scale genomic studies and precision medicine initiatives through its network of high-capacity laboratories and integrated data management systems.

Recent filings

Filing Released Lang Actions
诺禾致源2023年第三季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "2023 年第三季度报告" which translates to "2023 Third Quarter Report." It contains detailed financial data including income statements, balance sheets, cash flow statements, and shareholder information for the third quarter of 2023. The report explicitly states it is unaudited for the quarter and includes comprehensive financial metrics and analysis for the quarter and year-to-date periods. This matches the definition of an Interim / Quarterly Report (IR), which is a comprehensive financial report for a period shorter than a full fiscal year containing actual financial statements and substantive financial data. The document is about 15,000 characters long, indicating it is the full report rather than a brief announcement or certification. Therefore, the correct classification is Interim / Quarterly Report (IR).
2023-10-24 Chinese
北京市中伦律师事务所关于诺禾致源向特定对象发行A股股票发行过程和认购对象合规性的法律意见书
Regulatory Filings
2023-10-20 Chinese
中信证券股份有限公司关于北京诺禾致源科技股份有限公司向特定对象发行股票发行过程和认购对象合规性的报告
Capital/Financing Update Classification · 95% confidence The document is a detailed report from CITIC Securities Co., Ltd. regarding the compliance of a private placement (non-public issuance) of shares by Beijing Nuohe Zhiyuan Technology Co., Ltd. It includes extensive information about the issuance process, pricing, number of shares, investor subscription, regulatory approvals, internal decision-making procedures, and legal compliance. The document references regulatory approvals from the China Securities Regulatory Commission and Shanghai Stock Exchange, detailed subscription and allocation data, and verification of investor qualifications and fund sources. The document is not an announcement of a report but a substantive compliance report on a capital raising event involving issuance of shares to specific investors. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities. The document length (12,782 characters) and content confirm it is a full report, not a brief announcement or certification. Therefore, the appropriate classification is CAP with high confidence.
2023-10-20 Chinese
北京诺禾致源科技股份有限公司向特定对象发行 A 股股票募集资金验资报告-信会师报字[2023]第ZG11941号
Regulatory Filings
2023-10-20 Chinese
北京诺禾致源科技股份有限公司关于向特定对象发行股票发行情况的提示性公告
Capital/Financing Update Classification · 95% confidence The document is a short announcement (390 characters) regarding the company's issuance of A shares to specific investors. It mentions that the issuance summary documents have been filed with the Shanghai Stock Exchange and that the company will proceed with registration and custody of the new shares. It also references a detailed issuance report available on the exchange website. The document does not contain detailed financial data or the full issuance report itself, but rather serves as a notification of the issuance event and related filing. Therefore, it fits the category of a Capital/Financing Update (CAP).
2023-10-20 Chinese
北京诺禾致源科技股份有限公司向特定对象发行股票发行情况报告书
Capital/Financing Update Classification · 95% confidence The document is titled "北京诺禾致源科技股份有限公司 向特定对象发行股票 发行情况报告书" which translates to "Beijing Novogene Technology Co., Ltd. Report on the Issuance of Shares to Specific Objects." The content details the issuance of shares to specific investors, including the number of shares issued, pricing, subscription details, regulatory approvals, and signatures from company directors and supervisors. It includes detailed information about the issuance process, subscription, pricing, allotment, and legal compliance. This is a comprehensive report on a capital raising event through a private placement or directed share issuance. The document is not an announcement or a brief notice but a full report on the issuance event. Therefore, it fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities.
2023-10-20 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.